Results 181 to 190 of about 987,640 (269)
Distilling Knowledge in Gastroenterology: An Artificial Intelligence System for Assisting Colonoscopy and Pathology Report Review. [PDF]
Mau B +5 more
europepmc +1 more source
Construction of an XGBoost-SHAP-based malignant transformation risk prediction model for gallbladder polyps. [PDF]
Luo WH +5 more
europepmc +1 more source
ABSTRACT Advances in asthma therapies have shown that clinical remission may be an achievable therapeutic goal for patients with asthma. This review discusses the current definitions of remission in asthma, the predictors of remission, airway inflammation/epithelial damage in asthma remission, airway remodeling, paradigms in defining remission and ...
Fatma Esra Gunaydin +4 more
wiley +1 more source
Identification and analysis of endoplasmic reticulum stress-related biomarkers in chronic sinusitis with nasal polyps using bioinformatics approaches. [PDF]
Zhai Y, Lu H, Ding Q.
europepmc +1 more source
Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma
EXPEDITION (NCT02573233) assessed the effects of dupilumab on airway inflammation in patients with persistent asthma using bronchoscopy and gene expression analysis. Dupilumab showed no appreciable effect on inflammatory cell types in biopsies or BALF samples.
Michael E. Wechsler +22 more
wiley +1 more source
Morular Metaplasia in Fundic Gland Polyps-A Case Report of a Rare Finding in a Common Lesion. [PDF]
Kennedy B, Jacob D, Bernal K, Talmon G.
europepmc +1 more source
Dupilumab significantly improved nasal polyp score, nasal congestion, olfaction, total symptom score, and disease‐specific quality of life in Chinese patients with uncontrolled CRSwNP. Incidence of treatment‐emergent adverse events was similar between dupilumab and placebo.
Mu Xian +18 more
wiley +1 more source
Ultrasound-Guided Endometrial Polypectomy Performed in an Office Setting Without Hysteroscopy. [PDF]
Bayyarapu VB +3 more
europepmc +1 more source
Remission in Global Airway Diseases: EUFOREA Consensus Paper
ABSTRACT The therapeutic goal in chronic airway diseases is shifting from symptom control to disease remission. Disease‐modifying therapies, including biologics and allergen immunotherapy, have made remission achievable in patients with severe asthma, chronic rhinosinusitis with nasal polyps (CRSwNP), or allergic rhinitis (AR).
J. Christian Virchow +22 more
wiley +1 more source

